Skip to main content
SpringerLink
Log in

The effect of leukotriene antagonists, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigs

  • Allery, Histamine and Kinins
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Leukotrienes (LT) C4, D4, and E4 are major contributors to the pathobiology of human bronchial asthma. Therefore, it is likely that compounds that antagonize the action or inhibit the formation of LTs will be useful therapeutic agents. We have studied the effects of LT antagonists, 5-lipoxygenase inhibitors and selected standards in a model of LT-mediated allergic bronchospasm in guinea pigs. Sensitized animals were pretreated with mepyramine, indomethacin and propranolol to eliminate the influence of histamine, prostaglandins, thromboxanes and circulating catecholamines. In these animals, inhalation of antigen resulted in a bronchospasm consistent with a LT-mediated response that was slow in onset, of long duration and was inhibited by the selective LTD4, antagonists FPL-55712, LY-171,883 and ICI-198,615 ICI-198, 615 was approximately 50-times more potent than FPL-55712 by the intravenous and intratracheal routes. However, of thirteen compounds known to inhibit 5-lipoxygenase and LT biosynthesisin vitro only phenidone, piriprost and AA-861 were active in thisin vivo model. The allergic bronchospams was inhibited by bronchodilators (e.g. PGE2, aminophylline and forskolin) and by some mast cell stabilizers, but was otherwise insensitive to other pharmacological classes of compounds including calcium channel blockers and antagonists of serotonin, acetylcholine and platelet-activating factor. This model seems useful and reasonably selective for the evaluation of new antianaphylactic compounds that are LT antagonists. The inactivity of many 5-lipoxygenase inhibitors in this model suggests they do not inhibit LT formationin vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C. H. Kellaway and E. R. Trethewie,The liberation of a slow-reacting smooth muscle stimulating substance in anaphylaxis. Quat. J. Exp. Physiol.30, 121–145 (1940).

    Google Scholar 

  2. R. P. Orange and K. F. Austen,Slow-reacting substances of anaphylaxis. InAdvances in Immunology, vol. 10. (Ed. F. J. Dixon and H. G. Kunkel) pp 105–144, Academic Press, New York 1969.

    Google Scholar 

  3. E. J. Goetzl,Mediators of immediate hypersensitivity derived from arachidonic acid. N. Eng. J. Med.303, 822–825 (1980).

    Google Scholar 

  4. S. E. Dahlen, G. Hansson, P. Hedqvist T. Bjorck, E. Granstrom and B. Dahlen,Allergen challenge of lung tissue from asthmatics elicits bronchial contractions that correlate with the release of leukotrienes C 4,D 4,E 4. Proc. Natl. Acad. Sci. USA80, 1712–1716 (1983).

    PubMed  Google Scholar 

  5. S. E. Dahlen, G. Hansson, P. Hedqvist, S. Hammarstrom and B. Samuelsson,Leukotrienes are potent constrictors of human bronchi. Nature288, 484–486 (1980).

    PubMed  Google Scholar 

  6. P. Hedqvist, S. E. Dahlen, L. Gustafsson, S. Hammarstrom and B. Samuelsson,Biological profile of leukotrienes C 4 and D 4. Acta Physiol. Scand.110, 331–333 (1980).

    PubMed  Google Scholar 

  7. M. C. Holroyde, R. E. C. Altouynyan, M. Cole, M. Dixon and E. V. Elliot,Bronchoconstriction produced in man by leukotrienes C and D. Lancet2, 17–18 (1981).

    PubMed  Google Scholar 

  8. J. W. Weiss, J. M. Drazen and N. Cole,Bronchoconstrictor effects of leukotriene C in humans. Science216, 196–198. (1982).

    PubMed  Google Scholar 

  9. R. C. Murphy, S. Hammarstrom and B. Samuelsson,Leukotriene C, a slow-reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. USA76, 4275–4279 (1979).

    PubMed  Google Scholar 

  10. S. Hammarstrom, B. Samuelsson, D. A. Clark, G. Goto, A. Marfat, C. Miokowski and E. J. Corey,Stereochemistry of leukotriene C-1. Biochem. Biophys. Res. Commun.92, 946–953 (1980).

    PubMed  Google Scholar 

  11. H. R. Morris, G. W. Taylor, P. J. Piper and J. R. Tippins,Structure of slow-reacting substance of anaphylaxis from guinea pig lung. Nature285, 104–106 (1980).

    PubMed  Google Scholar 

  12. J. C. Delehunt, A. P. Perruchoud, L. Yerger, B. Marchette, J. S. Stevenson and W. M. Abraham,The role of slow-reacting substance of anaphylaxis in the late bronchial response after antigen challenge in allergic sheep. Am. Rev. Resp. Dis.130, 748–754 (1984).

    PubMed  Google Scholar 

  13. W. M. Abraham, A. Wanner, J. S. Stevenson and G. A. Chapman,The effect of an orally active leukotriene D 4 /E 4 antagonist LY-171883 on antigen-induced airway responses in allergic sheep. Prostaglandins31, 457–467 (1986).

    PubMed  Google Scholar 

  14. R. Patterson, R. Orange and K. E. Harris,A study of the effect of slow-reacting substances of anaphylaxis on the rhesus monkey airway. J. Allergy Clin. Immun.62, 371–377 (1978).

    PubMed  Google Scholar 

  15. H. G. Johnson, M. L. McNee, M. K. Bach and H. W. Smith,The activity of a new, novel inhibitor of leukotrine synthesis in rhesus monkey ascaris reactors. Int. Arch. Allergy appl. Immun.70, 169–173 (1983).

    Google Scholar 

  16. G. Brunet, H. Piechuta, R. Hamel, G. Holme and A. W. Ford-Hutchinson,Respiratory respones to leukotrienes and biologic amines in normal and hyperreactive rats. J. Immun.131, 434–438 (1983).

    PubMed  Google Scholar 

  17. D. M. Ritchie, J. N. Siercho, R. J. Capetola and M. E. Rosenthale,SRS-A mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo. Agents and Actions11, 396–401 (1981).

    PubMed  Google Scholar 

  18. W. H. Anderson, M. O'Donnell, B. A. Simko and A. F. Welton,An in vivo model for measuring antigen-induced SRS-A mediated bronchoconstriction and plasma SRS-A levels in the guinea pig. Br. J. Pharmacol.78, 67–74 (1983).

    PubMed  Google Scholar 

  19. P. Hedqvist, S. E. Dahlen and U. Palmertz,Leukotriene-dependent airway anaphylaxis in guinea pigs. Prostaglandins28, 605–608 (1984).

    Google Scholar 

  20. W. Kreutner, R. W. Chapman, A. Gulbenkian and S. Tozzi.Bronchodilator and antiallergy activity of forskolin. Eur. J. Pharmacol.111, 1–8 (1985).

    PubMed  Google Scholar 

  21. J. A. Zivin and J. J. Bartko,Statistics for disinterested scientists. Life Sci.18 15–26 (1976).

    PubMed  Google Scholar 

  22. R. W. Chapman and W. Kreutner,Comparison of the protective effect of orciprenaline with an orciprenaline-oxymetazoline combination on experimental bronchospasm in guinea pigs. Arzneim. Forsch.35, 1410–1412 (1985).

    Google Scholar 

  23. J. Augstein, J. B. Farmer, T. B. Lee, P. Sheard and M. L. Tattersall,Selective inhibitor of slow-reacting substance of anaphylaxis, Nature245, 215–217 (1973).

    PubMed  Google Scholar 

  24. J. H. Mussler, A. F. Kreft and A. J. Lewis,New developments concerning leukotriene antagonists. A review. Agents and Actions18, 332–341 (1986).

    PubMed  Google Scholar 

  25. D. W. Snyder, R. E. Giles, R. A. Keith, Y. K. Lee and R. D. Krell,In vitro pharmacology of ICI 198,615: A novel, potent and selective peptide leukotriene antagonist. J. Pharmacol. Exp. Ther.243, 548–556 (1987).

    PubMed  Google Scholar 

  26. R. G. Van Ingwegen, A. Khandwala, R. Gordon, P. Sonnino, S. Coutts and S. Jolly,Rev-5901. An orally effective peptido leukotriene antagonist, detailed biochemical-pharmacological profile. J. Pharmacol. Exp. Ther.241 117–124 (1987).

    PubMed  Google Scholar 

  27. M. Ohashi, R. Kanai, K. Nishino, T. Sato and I. Takayanagi,Antagonistic effect of KC-404, a new antiasthmatic agent on leukotriene D 4 -induced contractile responses in isolated guinea pig smooth muscles. Prostaglandins32, 875–888 (1986).

    PubMed  Google Scholar 

  28. G. J. Blackwell and R. J. Flower,1-Phenyl-3-pyrazolidine. An inhibitor of cyclooxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins16, 417–425 (1978).

    PubMed  Google Scholar 

  29. M. K. Bach, R. L. Griffin and I. M. Richards,Inhibition of the presumable leukotriene dependent component of antigeninduced bronchoconstriction in the guinea pig by piriprost (U-60,257). Int. Archs. Allergy appl. Immun.77, 264–266 (1985).

    Google Scholar 

  30. T. Yoshimoto, C. Yokoyama, K. Ochi, S. Yamamoto, Y. Maki, Y. Ashida, S. Terao and M. Shiraishi,2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl) 1,4-benzoquinone (AA-861), a selective inhibitor of the 5-lipoxygenase reactions and the biosynthesis of slow reacting substance of anaphylaxis. Biochem. Biophys. Acta713, 470–473 (1982).

    PubMed  Google Scholar 

  31. R. W. Randall, K. E. Eakins, G. A. Higgs, J. A. Salmon and J. E. Tateson,Inhibition of arachidonic acid cyclooxygenase and lipoxygenase activities of leukocytes by indomethacin and BW-755 C. Agents and Actions10, 553–555 (1980).

    PubMed  Google Scholar 

  32. J. R. Walker and W. Dawson,Inhibition of rabbit PMN lipoxygenase activity by benoxaprofen. J. Pharm. Pharmacol.31, 778–780 (1979).

    PubMed  Google Scholar 

  33. Y. Koshihara, T. Neichi, S. Murota, A. Lao, Y. Fujimoto and T. Tatsuno,Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochem. Biophys. Acta792, 92–97 (1984).

    PubMed  Google Scholar 

  34. H. R. Morris, P. J. Piper, G. W. Taylor and J. R. Tippins,The role of arachidonate lipoxygenase in the release of SRS-A from guinea pig chopped lung. Prostaglandins19, 371–383 (1980).

    PubMed  Google Scholar 

  35. J. Baumann, F. V. Bruchhausen and G. Wurm,Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins20, 627–639 (1980).

    PubMed  Google Scholar 

  36. T. Neichi, Y. Koshihara and S. Murota,Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochem. Biophys. Acta753, 130–132 (1983).

    PubMed  Google Scholar 

  37. J. R. Beetens, W. Loots, Y. Somers, M. C. Coene and F. DeClerck,Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem. Pharmacol.35, 883–891 (1986).

    PubMed  Google Scholar 

  38. M. S. Wu, T. Biftu and T. W. Duebber,Inhibition of the platelet activating factor-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist. J. Pharmacol. Exp. Ther.239, 841–845 (1986).

    PubMed  Google Scholar 

  39. K. V. Honn and J. R. Dunn,Nafazatrom (Bay g6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation. FEBS Letters139, 65–68 (1982).

    PubMed  Google Scholar 

  40. W. F. Stenson and E. Lobos,Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J. Clin. Invest.69, 494–497 (1982).

    PubMed  Google Scholar 

  41. I. Kennedy, M. Langley and C. J. Whelan,The release and metabolism of 3 H-arachidonic acid from guinea pig perfused lungs in vitro. A simple method for the study of the action of drugs on the release and metabolism of arachidonic acid. J. Pharmacol. Methods6, 143–151 (1981).

    PubMed  Google Scholar 

  42. D. M. Harris, R. Greenberg, M. B. Phillips, G. H. Osman and M. J. Antonaccio,The effect of SQ-80338, 1-(3-phenyl-2-propenyl)-1-H-imidazole on thromboxane synthetase activity and arachidonic acid-induced platelet aggregation and bronchoconstriction InAdvances in Prostaglandin and Thromboxane Research, vol. 6, (Eds B. Samuelsson, P. Ramwell and R. Paoletti) pp. 437, Raven Press, New York 1980.

    Google Scholar 

  43. R. Carrier, E. J. Cragoe, D. Ethier, A. W. Ford-Hutchinson, Y. Girard, R. A. Hall, P. Hamel, J. Rokach, N. N. Share, C. A. Stone and P. Yusko,Studies on L-640,035, a novel antagonist of contractile prostanoids in the lung. Br. J. Pharmacol.82, 389–395 (1984).

    PubMed  Google Scholar 

  44. M. K. Church and C. F. Gradidge,The activity of sodium cromoglycate analogues in human lung in vitro. A comparison with rat passive cutaneous anaphylaxis and clinical efficacy. Br. J. Pharmacol.70, 307–311 (1980).

    PubMed  Google Scholar 

  45. H. G. Johnson, R. L. Griffin and J. B. Wright,The effect of lodoxamide ethyl [diethyl-N,N′-(2-chloro-5-cyano-m-phenylene)-dioxamate] on in vivo anaphylactic reactions. Agents and Actions9, 235–238 (1979).

    PubMed  Google Scholar 

  46. J. El-Azab and P. B. Stewart,Pharmacologic profile of a new antiallergic compound PRD-92-Ea. Int. Archs. Allergy appl. Immun.55, 350–361 (1977).

    Google Scholar 

  47. H. Cairns, D. Cox, K. J. Gould, A. H. Ingall and J. L. Suschitsky,New antiallergic pyranc [3,2-g] quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma. J. Med. Chem.28, 1832–1842 (1985).

    PubMed  Google Scholar 

  48. J. L. Suschitsky and P. Sheard,The search for antiallergic drugs for the treatment of asthma. Problems in finding a successor to sodium cromoglycate InProgress in Medicinal Chemistry, vol. 21. (Eds G. P. Ellis and G. B. West) pp 1–61, Elsevier, B. V. 1984.

  49. J. Augstein, H. Cairns, D. Hunter, T. B. Lee, J. Suschitsky, R. E. C. Altouynan, D. M. Jackson, J. Mann, T. S. C. Orr and P. Sheard,New orally effective chromone derivatives for the treatment of asthma. Agents and Actions7, 443–445 (1977).

    PubMed  Google Scholar 

  50. T. Takashima, T. Ono, M. Ohtsuka and S. Kumada,The mode of action of antianaphylactic effect of tiaramide hydrochloride. Arzneim. Forsch.29, 903–910 (1979).

    Google Scholar 

  51. P. Simonoff, F. C. Reed and J. E. Schurig,BL-5255 activity in animal models of immediate hypersensitivity reactions. Int. Archs. Allergy appl. Immun.67, 101–108 (1982).

    Google Scholar 

  52. K. Strandberg and P. Hedqvist,Bronchial effects of some prostaglandin E and F analogues. Acta Physiol. Scand100, 172–181 (1977).

    PubMed  Google Scholar 

  53. M. K. Church,Biochemical basis of pulmonary and antiallergy drugs. InPulmonary and Antiallergic Drugs. (Ed J. P. Devlin) pp 101–102, John Wiley and Sons, New York 1985.

    Google Scholar 

  54. R. E. Ruffin and M. Newhouse,Dipyridamole, is it a bronchodilator. Eur. J. Resp. Dis.62, 123–126 (1981).

    Google Scholar 

  55. T. Asano and H. Hidaka,Intracellular Ca 2+ antagonist, HA-1004, Pharmacological properties different from those of nicardipine. J. Pharmacol. Exp. Ther.233 454–458 (1985).

    PubMed  Google Scholar 

  56. Z. Terashita, S. Tsushima, Y. Yoshioka, H. Nomura, Y. Inada and K. Nishikawa,CV-3988, a specific antagonist of platelet activating factor. Life Sci.32, 1975–1982 (1983).

    PubMed  Google Scholar 

  57. H. O. J. Collier and G. W. L. James,Humoral factors affecting pulmonary inflation during acute anaphylaxis in the guinea pig in vivo. Br. J. Pharmacol. Chemother.30, 283–301 (1967).

    Google Scholar 

  58. I. Broder, S. Rogers, D. W. Chamberlain and E. N. C. Milne,Model of allergic bronchoconstriction in the guinea pig. Clin. Immun. Immunopathol.9, 1–15 (1978).

    Google Scholar 

  59. A. K. Adams, III and L. Lichtenstein,In vitro studies of antigen-induced bronchospasm. Effect of antihistamine and SRS-A antagonist in response of sensitized guinea pig and human airways to antigen. J. Immun.122, 555–562 (1979).

    PubMed  Google Scholar 

  60. M. W. McCullough, C. Proctor and M. J. Rand,Evidence for an adrenergic homeostatic bronchodilator reflex mechanism. Eur. J. Pharmacol.2, 214–223 (1967).

    PubMed  Google Scholar 

  61. W. Kreutner and C. Rizzo,Labetalol protects against the potentiation by propranolol of the bronchospasm to norepinephrine in guinea pigs. Arch. Int. Pharmacodynamic Ther.285, 117–128 (1987).

    Google Scholar 

  62. P. Schiantarelli, S. Bongrani, R. Razzetti and G. Folco,Beta adrenoreceptor and cyclooxygenase block as a tool for evoking the direct bronchoconstrictor effect of leukotriene C 4 in the guinea pig. Eur. J. Pharmacol.106, 263–269 (1985).

    Google Scholar 

  63. W. E. Brokelhurst and S. C. Lahiri,The production of bradykinin in anaphylaxis. J. Physiol.160. 15P (1962).

  64. B. G. Simonsson and N. Svedmyr,Bronchoconstrictor drugs. Pharmacol. Ther.3, 239–303 (1978).

    Google Scholar 

  65. R. D. Krell, R. E. Giles, Y. K. Lee and D. W. Snyder,In vivo pharmacology of ICI-198,615: A novel, potent and selective peptide leukotriene antagonist. J. Pharmacol. Exp. Ther.243, 557–564 (1987).

    PubMed  Google Scholar 

  66. J. R. Boot, W. J. F. Sweatman, B. A. Cox, K. Stone and W. Dawson,The antiallergic activity of benoxaprofen, 2-(4-chlorophenyl)-α-methyl-5-benzoxazole acetic acid, a lipoxygenase inhibitor. Int. Archs Allergy appl. Immun.67, 340–343 (1982).

    Google Scholar 

  67. R. W. Fuller, N. Maltby, R. Richmond C. T. Dollery G. W. Taylor, W. Ritter and E. Phillip,Oral nafazatrom in man. Effect on inhaled antigen challenge. Br. J. Clin. Pharmacol.23, 677–681 (1987).

    PubMed  Google Scholar 

  68. F. Carey, D. Haworth, A. E. Edmonds and R. A. Forder,Simple procedure for measuring the pharmacodynamics and analgesic potential of lipoxygenase inhibitors. J. Pharmacol. Methods20, 347–356 (1988).

    PubMed  Google Scholar 

  69. K. Forsberg and L. Sorenby,The influence of a new corticosteroid, budesonide, on anaphylactic bronchoconstriction and SRS-A release in the guinea pig. Agents and Actions11, 391–395 (1985).

    Google Scholar 

  70. P. Andersson and R. Brattsand,Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea pigs. Inhibition of IgE, but not IgG-mediated anaphylaxis. Br. J. Pharmacol.76, 139–147 (1982).

    PubMed  Google Scholar 

  71. M. Kaliner,Mechanisms of glucocorticoid action in bronchial asthma J. Allergy Clin. Immun.,76, 321–329 (1985).

    PubMed  Google Scholar 

  72. A. J. Hodgson and J. W. Funder,Glucocorticoid receptors in the guinea pig. Am. J. Physiol.235, R115-R120 (1978).

    PubMed  Google Scholar 

  73. M. Hitchcock,Effect of inhibitors of prostaglandin synthesis and prostaglandins E 2 and F 2α on the immunologic release of mediators of inflammation from actively sensitized guinea pig lung. J. Pharmacol. Exp. Ther.207, 630–640 (1978).

    PubMed  Google Scholar 

  74. L. Hendeles and E. Harman,Should we abandon the notion that calcium channel blockers are potentially useful for asthma? J. Allergy Clin. Immun.79, 853–855 (1987).

    PubMed  Google Scholar 

  75. I. K. Krampetz and R. Bose,Relaxant effect of amiloride on canine tracheal smooth muscle. J. Pharmacol. Exp. Ther.246, 641–648 (1988).

    PubMed  Google Scholar 

  76. H. Ozaki, T. Kojima, T. Moriyama, H. Karaki, N. Urakawa, K. Kohama and Y. Nonomura,Inhibition by amiloride of contractile elements in smooth muscle of guinea pig taenia cecum and chicken gizzard. J. Pharmacol. Exp. Ther.243, 370–377 (1987).

    PubMed  Google Scholar 

  77. J. D. Sweatt, S. L. Johnson, E. J. Cragoe and L. E. Limbird,Inhibitors of Na + /H + exchange block stimulus-provoked arachidonic acid release in human platelets. J. Biol. Chem.260, 12910–12919 (1985).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Allergy and Inflammation, Schering-Plough Corporation, 60 Orange Street, 07003, Bloomfield, NJ, USA

    W. Kreutner, J. Sherwood & C. Rizzo

Authors
  1. W. Kreutner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Sherwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Rizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kreutner, W., Sherwood, J. & Rizzo, C. The effect of leukotriene antagonists, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigs. Agents and Actions 28, 173–184 (1989). https://doi.org/10.1007/BF01967398

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967398

Keywords

Search

Navigation